TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
TCL Archive In Brief: Jane Henney Sworn In As FDA Commissioner; Six Centers Retain Comprehensive Status December 18, 1998